• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

尤文肉瘤细胞系中EWS-FLI1的稳定干扰会损害IGF-1/IGF-1R信号传导,并揭示TOPK作为一个新靶点。

Stable interference of EWS-FLI1 in an Ewing sarcoma cell line impairs IGF-1/IGF-1R signalling and reveals TOPK as a new target.

作者信息

Herrero-Martín D, Osuna D, Ordóñez J L, Sevillano V, Martins A S, Mackintosh C, Campos M, Madoz-Gúrpide J, Otero-Motta A P, Caballero G, Amaral A T, Wai D H, Braun Y, Eisenacher M, Schaefer K-L, Poremba C, de Alava E

机构信息

Molecular Pathology Program, Centro de Investigación del Cáncer-IBMCC (USAL-CSIC), Campus Unamuno s/n, Salamanca, Spain.

出版信息

Br J Cancer. 2009 Jul 7;101(1):80-90. doi: 10.1038/sj.bjc.6605104. Epub 2009 Jun 2.

DOI:10.1038/sj.bjc.6605104
PMID:19491900
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2694277/
Abstract

BACKGROUND

Ewing sarcoma is a paradigm of solid tumour -bearing chromosomal translocations resulting in fusion proteins that act as deregulated transcription factors. Ewing sarcoma translocations fuse the EWS gene with an ETS transcription factor, mainly FLI1. Most of the EWS-FLI1 target genes still remain unknown and many have been identified in heterologous model systems.

METHODS

We have developed a stable RNA interference model knocking down EWS-FLI1 in the Ewing sarcoma cell line TC71. Gene expression analyses were performed to study the effect of RNA interference on the genetic signature of EWS-FLI1 and to identify genes that could contribute to tumourigenesis.

RESULTS

EWS-FLI1 inhibition induced apoptosis, reduced cell migratory and tumourigenic capacities, and caused reduction in tumour growth. IGF-1 was downregulated and the IGF-1/IGF-1R signalling pathway was impaired. PBK/TOPK (T-LAK cell-originated protein kinase) expression was decreased because of EWS-FLI1 inhibition. We showed that TOPK is a new target gene of EWS-FLI1. TOPK inhibition prompted a decrease in the proliferation rate and a dramatic change in the cell's ability to grow in coalescence.

CONCLUSION

This is the first report of TOPK activity in Ewing sarcoma and suggests a significant role of this MAPKK-like protein kinase in the Ewing sarcoma biology.

摘要

背景

尤因肉瘤是实体瘤中存在染色体易位的典型例子,这种易位会产生融合蛋白,这些融合蛋白作为失调的转录因子发挥作用。尤因肉瘤易位会将EWS基因与ETS转录因子(主要是FLI1)融合。大多数EWS-FLI1靶基因仍不为人知,许多已在异源模型系统中得到鉴定。

方法

我们构建了一个稳定的RNA干扰模型,在尤因肉瘤细胞系TC71中敲低EWS-FLI1。进行基因表达分析以研究RNA干扰对EWS-FLI1基因特征的影响,并鉴定可能有助于肿瘤发生的基因。

结果

EWS-FLI1抑制诱导细胞凋亡,降低细胞迁移和致瘤能力,并导致肿瘤生长减缓。IGF-1下调,IGF-1/IGF-1R信号通路受损。由于EWS-FLI1抑制,PBK/TOPK(T-LAK细胞起源的蛋白激酶)表达降低。我们证明TOPK是EWS-FLI1的一个新靶基因。TOPK抑制促使增殖率降低以及细胞聚集体生长能力发生显著变化。

结论

这是关于TOPK在尤因肉瘤中活性的首次报道,并表明这种类MAPKK蛋白激酶在尤因肉瘤生物学中具有重要作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b2a5/2713703/a14ca359d140/6605104f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b2a5/2713703/af1d44fc077d/6605104f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b2a5/2713703/845c291ed255/6605104f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b2a5/2713703/13c6550c6338/6605104f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b2a5/2713703/08bf483f5bdd/6605104f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b2a5/2713703/a14ca359d140/6605104f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b2a5/2713703/af1d44fc077d/6605104f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b2a5/2713703/845c291ed255/6605104f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b2a5/2713703/13c6550c6338/6605104f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b2a5/2713703/08bf483f5bdd/6605104f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b2a5/2713703/a14ca359d140/6605104f5.jpg

相似文献

1
Stable interference of EWS-FLI1 in an Ewing sarcoma cell line impairs IGF-1/IGF-1R signalling and reveals TOPK as a new target.尤文肉瘤细胞系中EWS-FLI1的稳定干扰会损害IGF-1/IGF-1R信号传导,并揭示TOPK作为一个新靶点。
Br J Cancer. 2009 Jul 7;101(1):80-90. doi: 10.1038/sj.bjc.6605104. Epub 2009 Jun 2.
2
BET bromodomain inhibitors suppress EWS-FLI1-dependent transcription and the IGF1 autocrine mechanism in Ewing sarcoma.BET溴结构域抑制剂可抑制尤因肉瘤中EWS-FLI1依赖的转录及IGF1自分泌机制。
Oncotarget. 2016 Jul 12;7(28):43504-43517. doi: 10.18632/oncotarget.9762.
3
Association of EWS-FLI1 type 1 fusion with lower proliferative rate in Ewing's sarcoma.EWS-FLI1 1型融合与尤因肉瘤增殖率较低的关联。
Am J Pathol. 2000 Mar;156(3):849-55. doi: 10.1016/S0002-9440(10)64953-X.
4
Inhibition of platelet-derived growth factor-induced cell growth signaling by a short interfering RNA for EWS-Fli1 via down-regulation of phospholipase D2 in Ewing sarcoma cells.在尤因肉瘤细胞中,通过下调磷脂酶D2,利用针对EWS-Fli1的短发夹RNA抑制血小板衍生生长因子诱导的细胞生长信号传导。
J Biol Chem. 2005 Jul 29;280(30):27544-51. doi: 10.1074/jbc.M411626200. Epub 2005 May 26.
5
Targeting the EWS-ETS transcriptional program by BET bromodomain inhibition in Ewing sarcoma.通过抑制尤文肉瘤中的BET溴结构域靶向EWS-ETS转录程序。
Oncotarget. 2016 Jan 12;7(2):1451-63. doi: 10.18632/oncotarget.6385.
6
EWS-FLI1-mediated suppression of the RAS-antagonist Sprouty 1 (SPRY1) confers aggressiveness to Ewing sarcoma.EWS-FLI1介导的对RAS拮抗剂Sprouty 1(SPRY1)的抑制赋予尤文肉瘤侵袭性。
Oncogene. 2017 Feb 9;36(6):766-776. doi: 10.1038/onc.2016.244. Epub 2016 Jul 4.
7
EWS-FLI1 regulates a transcriptional program in cooperation with Foxq1 in mouse Ewing sarcoma.EWS-FLI1 通过与 Foxq1 合作在小鼠尤文肉瘤中调节转录程序。
Cancer Sci. 2018 Sep;109(9):2907-2918. doi: 10.1111/cas.13710. Epub 2018 Jul 18.
8
CRM1 Inhibition Promotes Cytotoxicity in Ewing Sarcoma Cells by Repressing EWS-FLI1-Dependent IGF-1 Signaling.CRM1 抑制通过抑制 EWS-FLI1 依赖性 IGF-1 信号促进尤文肉瘤细胞的细胞毒性。
Cancer Res. 2016 May 1;76(9):2687-97. doi: 10.1158/0008-5472.CAN-15-1572. Epub 2016 Mar 8.
9
Pharmaceutical Interference of the EWS-FLI1-driven Transcriptome By Cotargeting H3K27ac and RNA Polymerase Activity in Ewing Sarcoma.EWS-FLI1 驱动的转录组通过靶向 Ewing 肉瘤中的 H3K27ac 和 RNA 聚合酶活性的药物干扰。
Mol Cancer Ther. 2021 Oct;20(10):1868-1879. doi: 10.1158/1535-7163.MCT-20-0489. Epub 2021 Jul 26.
10
Small-molecule screen identifies modulators of EWS/FLI1 target gene expression and cell survival in Ewing's sarcoma.小分子筛选鉴定出 EWS/FLI1 靶基因表达和尤文肉瘤细胞存活的调节剂。
Int J Cancer. 2012 Nov 1;131(9):2153-64. doi: 10.1002/ijc.27472. Epub 2012 Mar 29.

引用本文的文献

1
YAP1 is a key regulator of EWS::FLI1-dependent malignant transformation upon IGF-1-mediated reprogramming of bone mesenchymal stem cells.YAP1是在胰岛素样生长因子-1(IGF-1)介导的骨间充质干细胞重编程过程中,EWS::FLI1依赖性恶性转化的关键调节因子。
Cell Rep. 2025 Mar 25;44(3):115381. doi: 10.1016/j.celrep.2025.115381. Epub 2025 Mar 12.
2
Revisiting 'Hallmarks of Cancer' In Sarcomas.重新审视肉瘤中的“癌症特征”
J Cancer. 2024 Feb 4;15(7):1786-1804. doi: 10.7150/jca.92844. eCollection 2024.
3
EHD1-dependent traffic of IGF-1 receptor to the cell surface is essential for Ewing sarcoma tumorigenesis and metastasis.

本文引用的文献

1
Microsatellites are EWS/FLI response elements: genomic "junk" is EWS/FLI's treasure.微卫星是EWS/FLI反应元件:基因组“垃圾”是EWS/FLI的宝藏。
Cell Cycle. 2008 Oct;7(20):3127-32. doi: 10.4161/cc.7.20.6892. Epub 2008 Oct 2.
2
A pivotal role for heat shock protein 90 in Ewing sarcoma resistance to anti-insulin-like growth factor 1 receptor treatment: in vitro and in vivo study.热休克蛋白90在尤因肉瘤抗胰岛素样生长因子1受体治疗耐药中的关键作用:体内外研究
Cancer Res. 2008 Aug 1;68(15):6260-70. doi: 10.1158/0008-5472.CAN-07-3074.
3
Bidirectional signals transduced by TOPK-ERK interaction increase tumorigenesis of HCT116 colorectal cancer cells.
EHD1 依赖性 IGF-1 受体向细胞表面的转运对于尤文肉瘤的发生和转移是必需的。
Commun Biol. 2023 Jul 20;6(1):758. doi: 10.1038/s42003-023-05125-1.
4
Investigation of Flavonoid Scaffolds as DAX1 Inhibitors against Ewing Sarcoma through Pharmacoinformatic and Dynamic Simulation Studies.通过基于药物的计算和动态模拟研究调查黄酮类支架作为 DAX1 抑制剂对尤文肉瘤的作用。
Int J Mol Sci. 2023 May 26;24(11):9332. doi: 10.3390/ijms24119332.
5
Molecular Targets for Novel Therapeutics in Pediatric Fusion-Positive Non-CNS Solid Tumors.小儿融合基因阳性非中枢神经系统实体瘤新型治疗药物的分子靶点
Front Pharmacol. 2022 Jan 20;12:747895. doi: 10.3389/fphar.2021.747895. eCollection 2021.
6
Selective inhibition of HDAC6 regulates expression of the oncogenic driver EWSR1-FLI1 through the EWSR1 promoter in Ewing sarcoma.选择性抑制 HDAC6 通过 EWSR1 启动子调控尤文肉瘤中致癌驱动基因 EWSR1-FLI1 的表达。
Oncogene. 2021 Sep;40(39):5843-5853. doi: 10.1038/s41388-021-01974-4. Epub 2021 Aug 3.
7
The Role of IGF/IGF-IR-Signaling and Extracellular Matrix Effectors in Bone Sarcoma Pathogenesis.胰岛素样生长因子/胰岛素样生长因子-1受体信号传导及细胞外基质效应分子在骨肉瘤发病机制中的作用
Cancers (Basel). 2021 May 19;13(10):2478. doi: 10.3390/cancers13102478.
8
PBK/TOPK: An Effective Drug Target with Diverse Therapeutic Potential.PBK/TOPK:一种具有多种治疗潜力的有效药物靶点。
Cancers (Basel). 2021 May 6;13(9):2232. doi: 10.3390/cancers13092232.
9
Rationale for Early Detection of Translocation-Associated Sarcoma Biomarkers in Liquid Biopsy.液体活检中易位相关肉瘤生物标志物早期检测的原理
Cancers (Basel). 2021 Feb 16;13(4):824. doi: 10.3390/cancers13040824.
10
An inducible ectopic expression system of EWSR1-FLI1 as a tool for understanding Ewing sarcoma oncogenesis.EWSR1-FLI1 诱导性异位表达系统作为研究尤文肉瘤发生机制的工具。
PLoS One. 2020 Jun 5;15(6):e0234243. doi: 10.1371/journal.pone.0234243. eCollection 2020.
由TOPK-ERK相互作用转导的双向信号增强了HCT116结肠癌细胞的肿瘤发生。
Gastroenterology. 2007 Jul;133(1):219-31. doi: 10.1053/j.gastro.2007.04.048. Epub 2007 Apr 25.
4
T-lymphokine-activated killer cell-originated protein kinase functions as a positive regulator of c-Jun-NH2-kinase 1 signaling and H-Ras-induced cell transformation.T淋巴细胞激活的杀伤细胞源蛋白激酶作为c-Jun氨基末端激酶1信号传导和H-Ras诱导的细胞转化的正向调节因子发挥作用。
Cancer Res. 2007 Jun 1;67(11):5186-94. doi: 10.1158/0008-5472.CAN-06-4506.
5
A mitotic kinase TOPK enhances Cdk1/cyclin B1-dependent phosphorylation of PRC1 and promotes cytokinesis.有丝分裂激酶TOPK增强PRC1的Cdk1/细胞周期蛋白B1依赖性磷酸化并促进胞质分裂。
J Mol Biol. 2007 Jul 6;370(2):231-45. doi: 10.1016/j.jmb.2007.04.067. Epub 2007 May 3.
6
Cholecystokinin down-regulation by RNA interference impairs Ewing tumor growth.通过RNA干扰下调胆囊收缩素会损害尤因肉瘤的生长。
Clin Cancer Res. 2007 Apr 15;13(8):2429-40. doi: 10.1158/1078-0432.CCR-06-1762.
7
Signature-based small molecule screening identifies cytosine arabinoside as an EWS/FLI modulator in Ewing sarcoma.基于特征的小分子筛选确定阿糖胞苷为尤因肉瘤中EWS/FLI的调节剂。
PLoS Med. 2007 Apr;4(4):e122. doi: 10.1371/journal.pmed.0040122.
8
Alternative pathway of transcriptional induction of p21WAF1/Cip1 by cyclosporine A in p53-deficient human glioblastoma cells.环孢素A在p53缺陷型人胶质母细胞瘤细胞中诱导p21WAF1/Cip1转录的替代途径。
Cell Signal. 2007 Jun;19(6):1268-78. doi: 10.1016/j.cellsig.2007.01.011. Epub 2007 Jan 20.
9
PBK/TOPK promotes tumour cell proliferation through p38 MAPK activity and regulation of the DNA damage response.PBK/TOPK通过p38丝裂原活化蛋白激酶活性和DNA损伤反应的调节来促进肿瘤细胞增殖。
Oncogene. 2007 May 24;26(24):3451-61. doi: 10.1038/sj.onc.1210142. Epub 2006 Dec 11.
10
Lymphokine-activated killer T-cell-originated protein kinase phosphorylation of histone H2AX prevents arsenite-induced apoptosis in RPMI7951 melanoma cells.淋巴细胞激活的杀伤T细胞起源蛋白激酶对组蛋白H2AX的磷酸化作用可防止亚砷酸盐诱导的RPMI7951黑色素瘤细胞凋亡。
Clin Cancer Res. 2006 Dec 1;12(23):6884-93. doi: 10.1158/1078-0432.CCR-06-0410.